Follow the people · Insider
Patrick Lin
Patrick Lin files insider transactions with the SEC as a chief business - strategy off of Processa Pharmaceuticals (PCSA). We hold 7 disclosed purchases and sales filed since 5 October 2020, 2 of them in the last 90 days.
- Files forPCSA
- Disclosed buys and sells7 in all, 2 in the last 90 days
- Last disclosure1 July 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 1 October 2020 — 26 July 2026Chief Business - Strategy Off · Processa Pharmaceuticals (PCSA)64 Form 4 lines · source: SEC Form 4
Everything they disclosed
64 entries, newest first — one per disclosure report, one per Form 4 line- was granted 8,450 shares of Processa Pharmaceuticals (a derivative holding)SEC Form 428 July 2026Restricted Stock Units · traded 26 July 2026 · filed 28 July 2026
- ▲ bought on the open market 2,106 shares of Processa PharmaceuticalsSEC Form 41 July 2026Common Stock · traded 30 June 2026 · filed 1 July 2026
- ▲ bought on the open market 1,831 shares of Processa PharmaceuticalsSEC Form 416 June 2026Common Stock · traded 15 June 2026 · filed 16 June 2026
- ▲ bought on the open market 1,582 shares of Processa PharmaceuticalsSEC Form 41 June 2026Common Stock · traded 29 May 2026 · filed 1 June 2026
- ▲ bought on the open market 1,369 shares of Processa PharmaceuticalsSEC Form 419 May 2026Common Stock · traded 15 May 2026 · filed 19 May 2026
- ▲ bought on the open market 1,511 shares of Processa PharmaceuticalsSEC Form 41 May 2026Common Stock · traded 30 April 2026 · filed 1 May 2026
- ▲ bought on the open market 1,369 shares of Processa PharmaceuticalsSEC Form 417 April 2026Common Stock · traded 15 April 2026 · filed 17 April 2026
- ▲ bought on the open market 1,603 shares of Processa PharmaceuticalsSEC Form 41 April 2026Common Stock · traded 31 March 2026 · filed 1 April 2026
- exercised options over 193 shares of Processa PharmaceuticalsSEC Form 44 February 2026Common Stock · traded 1 January 2026 · filed 4 February 2026
- exercised options over 193 shares of Processa Pharmaceuticals (a derivative holding)SEC Form 44 February 2026Common Stock · traded 1 January 2026 · filed 4 February 2026
- exercised options over 193 shares of Processa Pharmaceuticals (a derivative holding)SEC Form 44 February 2026Common Stock · traded 1 January 2026 · filed 4 February 2026
- exercised options over 193 shares of Processa PharmaceuticalsSEC Form 44 February 2026Common Stock · traded 1 January 2026 · filed 4 February 2026
- was granted 68,000 shares of Processa Pharmaceuticals (a derivative holding)SEC Form 43 October 2025Restricted Stock Units · traded 1 October 2025 · filed 3 October 2025
- was granted 204,000 shares of Processa Pharmaceuticals (a derivative holding)SEC Form 43 October 2025Stock Options (Right to Buy) · traded 1 October 2025 · filed 3 October 2025
- was granted 1,401,650 shares of Processa Pharmaceuticals (a derivative holding)SEC Form 428 July 2025Restricted Stock Units · traded 24 July 2025 · filed 28 July 2025
- exercised options over 14,482 shares of Processa PharmaceuticalsSEC Form 411 April 2025Common Stock · traded 1 April 2025 · filed 11 April 2025
- had shares withheld for tax on 4,814 shares of Processa PharmaceuticalsSEC Form 411 April 2025Common Stock · traded 1 April 2025 · filed 11 April 2025
- was granted 43,500 shares of Processa Pharmaceuticals (a derivative holding)SEC Form 418 February 2025Warrants · traded 29 January 2025 · filed 18 February 2025
- was granted 21,750 shares of Processa Pharmaceuticals (a derivative holding)SEC Form 418 February 2025Warrants · traded 29 January 2025 · filed 18 February 2025
- ▲ bought on the open market 43,500 shares of Processa PharmaceuticalsSEC Form 429 January 2025Common Stock · traded 27 January 2025 · filed 29 January 2025
- was granted 2,713 shares of Processa Pharmaceuticals (a derivative holding)SEC Form 42 August 2024Restricted Stock Units · traded 28 June 2024 · filed 2 August 2024
- was granted 2,035 shares of Processa Pharmaceuticals (a derivative holding)SEC Form 42 August 2024Restricted Stock Units · traded 28 June 2024 · filed 2 August 2024
- was granted 339 shares of Processa Pharmaceuticals (a derivative holding)SEC Form 42 August 2024Restricted Stock Units · traded 28 June 2024 · filed 2 August 2024
- was granted 339 shares of Processa Pharmaceuticals (a derivative holding)SEC Form 42 August 2024Restricted Stock Units · traded 28 June 2024 · filed 2 August 2024
- exercised options over 1,675 shares of Processa PharmaceuticalsSEC Form 42 August 2024Common Stock · traded 5 April 2024 · filed 2 August 2024
- had shares withheld for tax on 539 shares of Processa PharmaceuticalsSEC Form 42 August 2024Common Stock · traded 5 April 2024 · filed 2 August 2024
- exercised options over 644 shares of Processa PharmaceuticalsSEC Form 42 August 2024Common Stock · traded 10 July 2024 · filed 2 August 2024
- had shares withheld for tax on 271 shares of Processa PharmaceuticalsSEC Form 42 August 2024Common Stock · traded 10 July 2024 · filed 2 August 2024
- exercised options over 1,675 shares of Processa Pharmaceuticals (a derivative holding)SEC Form 412 April 2024Restricted Stock Units · traded 1 January 2024 · filed 12 April 2024
- exercised options over 1,675 shares of Processa PharmaceuticalsSEC Form 412 April 2024Common Stock · traded 1 January 2024 · filed 12 April 2024
- had shares withheld for tax on 539 shares of Processa PharmaceuticalsSEC Form 412 April 2024Common Stock · traded 1 January 2024 · filed 12 April 2024
- ▲ bought on the open market 2,500 shares of Processa PharmaceuticalsSEC Form 41 February 2024Common Stock · traded 31 January 2024 · filed 1 February 2024
- ▲ bought on the open market 1,500 shares of Processa PharmaceuticalsSEC Form 41 February 2024Common Stock · traded 1 February 2024 · filed 1 February 2024
- was granted 5,000 shares of Processa PharmaceuticalsSEC Form 412 October 2023Common Stock · traded 12 October 2023 · filed 12 October 2023
- was granted 13,700 shares of Processa PharmaceuticalsSEC Form 410 October 2023Common Stock · traded 10 October 2023 · filed 10 October 2023
- was granted 12,500 shares of Processa PharmaceuticalsSEC Form 410 February 2023Common Stock · traded 9 February 2023 · filed 10 February 2023
- was granted 10,851 shares of Processa Pharmaceuticals (a derivative holding)SEC Form 44 January 2023Restricted Stock Units · traded 31 December 2022 · filed 4 January 2023
- was granted 55,107 shares of Processa Pharmaceuticals (a derivative holding)SEC Form 44 January 2023Restricted Stock Units · traded 1 January 2023 · filed 4 January 2023
- was granted 40,690 shares of Processa Pharmaceuticals (a derivative holding)SEC Form 44 January 2023Restricted Stock Units · traded 1 January 2023 · filed 4 January 2023
- was granted 10,850 shares of Processa Pharmaceuticals (a derivative holding)SEC Form 43 October 2022Restricted Stock Units · traded 30 September 2022 · filed 3 October 2022
- exercised options over 7,601 shares of Processa PharmaceuticalsSEC Form 49 August 2022Common Stock · traded 5 August 2022 · filed 9 August 2022
- had shares withheld for tax on 2,656 shares of Processa PharmaceuticalsSEC Form 49 August 2022Common Stock · traded 5 August 2022 · filed 9 August 2022
- was granted 20,064 shares of Processa Pharmaceuticals (a derivative holding)SEC Form 45 July 2022Restricted Stock Units · traded 30 June 2022 · filed 5 July 2022
- ▲ bought on the open market 2,000 shares of Processa PharmaceuticalsSEC Form 419 May 2022Common Stock · traded 17 May 2022 · filed 19 May 2022
- was granted 247,841 shares of Processa Pharmaceuticals (a derivative holding)SEC Form 411 April 2022Restricted Stock Units · traded 1 April 2022 · filed 11 April 2022
- ▲ bought on the open market 1,200 shares of Processa PharmaceuticalsSEC Form 48 April 2022Common Stock · traded 6 April 2022 · filed 8 April 2022
- ▲ bought on the open market 800 shares of Processa PharmaceuticalsSEC Form 48 April 2022Common Stock · traded 7 April 2022 · filed 8 April 2022
- was granted 4,286 shares of Processa Pharmaceuticals (a derivative holding)SEC Form 44 April 2022Restricted Stock Units · traded 1 November 2021 · filed 4 April 2022
- was granted 10,715 shares of Processa Pharmaceuticals (a derivative holding)SEC Form 44 April 2022Restricted Stock Units · traded 31 March 2022 · filed 4 April 2022
- was granted 6,024 shares of Processa Pharmaceuticals (a derivative holding)SEC Form 46 January 2022Restricted Stock Units · traded 30 September 2021 · filed 6 January 2022
- was granted 6,722 shares of Processa Pharmaceuticals (a derivative holding)SEC Form 46 January 2022Restricted Stock Units · traded 31 December 2021 · filed 6 January 2022
- ▲ bought on the open market 3,000 shares of Processa PharmaceuticalsSEC Form 44 January 2022Common Stock · traded 14 December 2021 · filed 4 January 2022
- ▲ bought on the open market 3,000 shares of Processa PharmaceuticalsSEC Form 416 December 2021Common Stock · traded 14 December 2021 · filed 16 December 2021
- ▲ bought on the open market 3,500 shares of Processa PharmaceuticalsSEC Form 47 December 2021Common Stock · traded 3 December 2021 · filed 7 December 2021
- was granted 6,024 shares of Processa Pharmaceuticals (a derivative holding)SEC Form 44 October 2021Restricted Stock Units · traded 30 September 2021 · filed 4 October 2021
- ▲ bought on the open market 4,000 shares of Processa PharmaceuticalsSEC Form 430 August 2021Common Stock · traded 26 August 2021 · filed 30 August 2021
- was granted 7,601 shares of Processa PharmaceuticalsSEC Form 49 August 2021Common Stock · traded 5 August 2021 · filed 9 August 2021
- was granted 8,572 shares of Processa Pharmaceuticals (a derivative holding)SEC Form 49 July 2021Restricted Stock Units · traded 8 July 2021 · filed 9 July 2021
- was granted 12,858 shares of Processa Pharmaceuticals (a derivative holding)SEC Form 49 July 2021Restricted Stock Units · traded 8 July 2021 · filed 9 July 2021
- was granted 1,907 shares of Processa Pharmaceuticals (a derivative holding)SEC Form 49 July 2021Restricted Stock Units · traded 8 July 2021 · filed 9 July 2021
- ▲ bought on the open market 2,000 shares of Processa PharmaceuticalsSEC Form 422 June 2021Common Stock · traded 21 June 2021 · filed 22 June 2021
- was granted 8,127 shares of Processa Pharmaceuticals (a derivative holding)SEC Form 410 June 2021Restricted Stock Units · traded 8 June 2021 · filed 10 June 2021
- ▲ bought on the open market 31,250 shares of Processa PharmaceuticalsSEC Form 45 October 2020Common Stock · traded 1 October 2020 · filed 5 October 2020
- ▲ bought on the open market 31,250 shares of Processa PharmaceuticalsSEC Form 45 October 2020Common Stock · traded 1 October 2020 · filed 5 October 2020
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.